Related Experiment Video
Updated: Jun 25, 2026

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
Upregulation of the CD40-CD40 ligand system in pre-eclampsia
Tzvetan Hristoforov Lukanov1, Svetla Ivanova Bojinova, Alkan Levha Emin
1Immunology Laboratory, University Hospital, Pleven, Bulgaria. lukanovtz@abv.bg
Insights
Pre-eclampsia is linked to an overactive CD40-CD40 ligand (CD40L) system. This immune system activation may drive inflammation and clotting in pre-eclampsia.
Area of Science:
- Immunology
- Obstetrics
- Cardiovascular Biology
Background:
- Pre-eclampsia is a serious pregnancy complication.
- The CD40-CD40 ligand (CD40L) system plays a role in immune and vascular function.
Purpose of the Study:
- To investigate the CD40-CD40 ligand (CD40L) system in women with pre-eclampsia.
- To compare CD40 and CD40L expression and levels in pre-eclamptic versus normotensive pregnant women.
Main Methods:
- Whole blood flow cytometry was used to measure CD40 on monocytes and CD40/CD40L on platelets.
- Serum levels of soluble CD40L were quantified using enzyme-linked immunosorbent assay (ELISA).
- The study included 23 women with pre-eclampsia and 23 normotensive pregnant controls.
Main Results:
- Women with pre-eclampsia exhibited significantly higher expression of CD40 on monocytes.
- Platelet expression of both CD40 and CD40L was significantly elevated in pre-eclamptic women.
- Serum concentrations of soluble CD40L were significantly higher in the pre-eclampsia group.
Conclusions:
- Pre-eclampsia is associated with significant activation of the CD40-CD40L system.
- This activation may contribute to the pro-inflammatory and pro-thrombotic state in pre-eclampsia.
- The CD40-CD40L system's role in endothelial dysfunction and cytokine production in pre-eclampsia warrants further investigation.
Objective:
To investigate the CD40-CD40 ligand (CD40L) system in women with pre-eclampsia.
Methods:
Expression of CD40 on monocytes and expression of CD40 and CD40L on platelets were determined by whole blood flow cytometry in 23 women with pre-eclampsia and in 23 normotensive pregnant women. Serum levels of soluble CD40L in both groups of women were measured by enzyme-linked immunosorbent assay.
Results:
There was a significantly higher expression of CD40 and CD40L on platelets and CD40 on monocytes in the women with pre-eclampsia compared with normotensive pregnant women (P<0.001 for all comparisons). The serum concentration of soluble CD40L was significantly higher in women with pre-eclampsia compared with normotensive pregnant women (P=0.012).
Conclusion:
Pre-eclampsia is associated with activation of the CD40-CD40L system. The activation of this system may contribute to the development or maintenance of the proinflammatory and prothrombotic responses, increased cytokine production, and endothelial cell dysfunction found in pre-eclampsia.
Related Concept Videos
Hormonal Regulation
Regulation of Angiogenesis and Blood Supply
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
